Johnson & Johnson plans to launch Covid-19 vaccine in India

As a government official said on Tuesday, Johnson & Johnson is involved in developing its Covid-19 vaccine in India.

Vinod Kumar Paul, member (health and nutrition), NITI Aayog, said that India is also not worried about the safety of the AstraZeneca vaccine that is being used in the country’s major inoculation program.

In addition, the Serum Institute today announced that the Indian government has ordered an additional 10 million doses of AstraZeneca COVID-19 vaccine for its people.

The world’s largest vaccine-making corporation has previously given 11 million doses to the inoculation program of the government that started in January 2021.

“The second order is already in place, it’s for 10 million doses,” said the SII spokesperson, he added that the figure was part of the 100 million doses that the corporation planned to sell for $200 ($2.74) each to the government.

The Indian Government is actively using AstraZeneca’s Covishield vaccines from the Serum Institute and Bharat Biotech’s COVAXIN. In what India calls the largest immunization campaign in the country, the two shots were used to protect 300 million people by August, beginning with healthcare and other staff to meet the aged and others with existing conditions by March.

Russian Sputnik V and Cadila Healthcare ZyCov-D vaccines are expected to be approved by the regulator in the next few months.

India’s infections have risen 9.110 in the last 24 hours to 10.85 million, the world’s highest count since the United States, but they have declined dramatically from a height of nearly 100k in mid-September.

The Ministry of Health has announced a daily toll of fewer than 100 deaths over the last four days, taking the number to more than 155,000.

363 K